Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO ISIN · CA46604F1099 LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2022-09-28 Regulatory Filings
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2022-09-28 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-09-28 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings for the financial year ended April 30, 2022. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the annual filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the actual annual report (10-K) or other financial reports.
2022-08-27 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO certifying the review and fair presentation of the annual filings for the financial year ended April 30, 2022. It is a certification letter related to annual filings, not the filings themselves. The document is short (3126 characters) and primarily an officer certification. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the actual annual report or financial statements.
2022-08-27 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) and is dated August 26, 2022. It reviews operations, financial position, and outlook, and references the company's audited consolidated financial statements for the year ended April 30, 2022. The content includes detailed discussion of corporate activities, forward-looking statements, and operational updates. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The MD&A is a management report explaining financial results and business trends, which fits the definition of Management Reports (MDA). It is not an Annual Report (10-K) as it does not contain full financial statements but refers to them. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive analysis and discussion, not just a notice or certification. Therefore, the correct classification is Management Reports (MDA).
2022-08-27 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-502F1 related to participation fees for Class 1 and Class 3B reporting issuers, submitted to the Ontario Securities Commission. It contains a management certification by an officer of the reporting issuer, certifying the completeness and accuracy of the information provided. The content focuses on market values, trading periods, and fee calculations rather than financial performance or detailed financial statements. There is no indication of this being an annual or interim financial report, audit report, or earnings release. The document is a regulatory filing related to fee reporting and certification to a securities commission, which fits best under the Regulatory Filings (RNS) category as it does not fit other specific categories and is primarily a certification and fee calculation form.
2022-08-27 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.